Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults (PRIMALVAC)
Phase Ia/Ib, Randomized, Double Blinded, Dose Escalation Trial to Evaluate the Safety and Immunogenicity in Healthy European and Burkinabe Adults of a Placental Malaria Vaccine Candidate (PRIMVAC) Formulated With Alhydrogel ® or GLA-SE
Sponsor: Centre national de recherche et de formation sur le paludisme
A PHASE1 clinical study on Malaria, this trial is completed. The trial is conducted by Centre national de recherche et de formation sur le paludisme and has accumulated 16 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
16 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE1
-
Mar 2025 — Jan 2026 [monthly]
Completed PHASE1
-
Sep 2024 — Mar 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Oct 2021 — Jul 2024 [monthly]
Completed PHASE1
▶ Show 11 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Completed PHASE1
-
May 2020 — Jan 2021 [monthly]
Completed PHASE1
-
Dec 2019 — May 2020 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
-
Mar 2019 — Dec 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Active Not Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE1
Status: Unknown Status → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Unknown Status PHASE1
-
May 2018 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Recruiting → Unknown Status
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE1
First recorded
Jan 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre national de recherche et de formation sur le paludisme
- EUCLID Clinical Trial Platform
- European Vaccine Initiative
- Institut National de la Santé Et de la Recherche Médicale, France
- Recherche Clinique Paris Descartes Necker Cochin Sainte Anne
For direct contact, visit the study record on ClinicalTrials.gov .